This document provides information about blood group antigens and the ABO blood group system. It discusses the key discoveries in blood grouping including the identification of the A, B, AB, and O blood groups. It describes Landsteiner's laws of blood grouping and the genetics underlying the ABO system. The antigens are sugars attached to red blood cells, with the A, B, and O groups depending on whether the A or B enzyme adds specific sugars to the H antigen. Factors affecting antigen-antibody reactions and the rare Bombay phenotype are also summarized.
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
Antigen ,Antibody and Ag-Ab reactions ppt by DR.C.P.PRINCEDR.PRINCE C P
An immunogen refers to a molecule that is capable of eliciting an immune response, whereas an antigen refers to a molecule that is capable of binding to the product of that immune response (Ab).
So, an immunogen is necessarily an antigen, but an antigen may not necessarily be an immunogen
The terms immunogen and antigen are often used interchangeably but the later is more common.
Antibodies are Globulin Protein (Immunoglobulin) that are synthesized in the Serum and Tissue fluids.
It reacts specifically with the antigen that stimulated their production.
There are two types serum proteins: albumin and globulin
There are Three types of globulins .
1. Alpha globulin
2. Beta globulin
3. Gamma globulin (Antibodies)
Gamma globulins are responsible for immunity. So they are called as Immunoglobulin (Ig)
The binding of an antibody with an antigen of the type that stimulated the formation of antibody that results in the following reaction
Agglutination
Precipitation
Complement fixation
Phagocytosis
Neutralization of an exotoxin
Opsonization
Tissue fixation
Chemotaxis
Activation of mast cells and basophils
PPT prepared by:
DR.PRINCE C P
Associate Professor , Department of Microbiology,
Mother Theresa Post Graduate & Research Institute of Health Sciences (Government of Puducherry Institution)
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
3. Discovery
Karl Landsteiner(1990) discovered human A, B, O groups.
Van Deacastello and Sturli (1902) discovered AB blood group.
Von Sungern and Kirzsledl (1911) divided group A into 2 subgroups, A1 and A2.
ABO system is classified into 6 groups: A1, A2, A1B, A2B, B, AB and O.
3
4. Landsteiner’s Law
1. If an agglutinogen is present on red blood cell membrane, the corresponding agglutinin
must be absent in the plasma.
2. If an agglutinogen is absent on red blood cell membrane, the corresponding agglutinin
must be present in the plasma.
4
8. Antigen location
Human antigens are found on cells, organs, and tissues as well as in plasma and
other body fluids.
protrude from cell surface
Physical location - on cell membrane (eg. ABO ag)
integral part of the membrane
(eg. Rh Ag)
8
10. ABO antigen
Blood group antigens are actually sugars attached to the red blood cell.
Antigens are built onto the red cell.
Individuals inherit a gene which codes for specific sugar to
be added to the red cell.
The type of sugar added determines the blood group.
10
11. ABO Antigen
Appear in the sixth week of fetal life and remain unchanged until death.
Human red cells contain on their surface a series of glycoprotein and glycolipid
blood group antigen
11
12. ABO Antibodies
Can be classified as
1. Naturally occurring and immune antibodies
Depending on presensitization
2. Complete and incomplete antibodies
Depends on aggulutination of saline suspended red cells
IgM is complete antibody, most naturally occurring antiboides are complete and of IgM class
Ig G is incomplete antibody
3. Cold and warm antibody
thermal range of antibodies
Most natural antibodies are cold and some e.g. wide thermal range like Anti A and Anti B
Most immune antibodies are warm and can destroy red cell in vivo
12
13. Naturally occurring antibodies
Almost all normal healthy individuals above 3-6 months of age have “ Naturally
occurring antibodies” to the ABO antigens that they lack
Peak at 5-10 yrs
Decline progressively with advanced age.
These Abs termed Naturally occurring because they were thought to arise without
antigenic stimulation.
These naturally occurring Abs are mostly IgM class. That means that,they are Abs
capable of aggulutinating saline/low protein suspended red cell without
enhancement and may activate complement cascade.
13
14. Immune or acquired antibodies
Produced as a result of stimulation by a red cell antigen which is not present on his
own red cell or in his body fluid.
Arise from blood transfusion or the intravenous or intramuscular injection of blood
or injection of substances which are chemically closely related to a red cell antigen
or as a result of pregnancy.
More often IgG
Most importance in transfusion is IgG which can pass through the placenta during
pregnancy.
14
15. Complete antibody and incomplete antibody
Compete antibody
- produced without any antigenic stimulus
- most ofen IgM
- capable of aggulutinating red cells
suspended in normal saline at 20-25 C
Incomplete antibody
- requires a bridge like the Coomb’s sera
for bilnding to the antigenic site
- most IgG
15
17. Detection of antibodies
1. Saline aggulutination method
2. Albumin agglutination method
3. Test using enzyme treated cells
4. The indirect antiglobuliln (Coomb’s tsest)
17
18. Antigen-Antibody reaction
Red cell Ag-Ab reaction can detected by a number of techniques
Most frequently used
Hemolysis
Agglutination
Used as indicator of Ag-Ab reaction
18
19. Agglutination Reactions
Two Stage Process:
Stage 1 Sensitization:
attachment of Antibody to Antigen on the RBC membrane.
Stage 2 Lattice formation (agglutination):
formation of bridges between the sensitized red cells to form the lattice that constitutes agglutination.
19
20. This represents what occurs during stage one of
agglutination.
• Antibody molecules attach to their corresponding
antigenic site (epitope) on the red blood cell membrane.
• There is no visible clumping.
• Red cells must be close enough for the Fab portion of
Ab to bind and make bridges between cells
Stage 1: Sensitization
20
21. Stage 2: Lattice Formation
This represents what occurs during stage 2 of agglutination:
Antibody molecules crosslink RBCs forming a lattice that
results in visible clumping or agglutination.
21
22. Sensitization by IgG does not result in agglutination
IgG is too small to span the distance between two red cells
IgM can easily cause agglutination
For agglutination to occur, the repulsive forces keeping red cells apart must be
overcome
22
24. The Zeta Potential
The electric repulsion between cells
This explains why cells do not agglutinate
Red cells have negative charge due to
sialic acid molecules
When red cells are in solution containing
free ions:
Cations are attracted to the –vely charged red
cells
This forms a repelling cloud around the cell
24
25. The Zeta Potential can
be varied by altering the
charge on red cells
This can affect both
sensitization and
agglutination
Reducing the cloud
density allow Abs to
approach the cells,
sensitize and then
agglutinate them
25
27. 3. Increase the ionic strength of the medium
Increasing conc. of cations in medium cause
Increase in the density of ions around the red cell which cause
Size of cloud of cations is decreased
Zeta potential decreases
Red cell approach each other easily
Agglutination is facilitated
27
28. 4. Decreasing the ionic strength of medium by using low
ionic strength saline (LISS)
Decreasing conc. of cations in medium
Leads to decrease in density of ions around red cells
This increases sensitization
But decreases agglutination
28
29. Factors affecting Red Cell Sensitization
1. Ratio of Ab to Ag
Sensitization occurs easily when at higher conc. of Ab
This can be done by increasing conc. of serum containing
the Ab to conc. of cells
29
30. Factors affecting Red Cell Sensitization
2- The pH of reaction mixture
At a pH below the pI, Abs have
+ve charges
This makes it easier for the Ab
to bind to the –vely charged
red cells
Optional pH for sensitization is
6.5 to 7.5 (Ab +vely charged)
pH 8 pH 7
30
31. 3- Temperature
Ag- Ab reactions are exothermic
Therefore, Abs bind to a greater degree at lower temperature
But at lower temperatures, rate of reaction is reduced
To speed up reaction, tests are done at 37oC
31
32. Temperature can also affect Ag accessibility on red cells
Some IgM Abs bind best at 4oC (cold Abs)
Temperature can make conformational changes in the Ag
More Ag sites are exposed as the temperature is lowered allowing
increased binding of Ab
Most naturally occurring cold Abs are of no clinical
significance
Compatibility testing is done at 37C
4oC 37oC
32
33. 4. Ionic strength of the medium
When RBCs are suspended in LISS the cloud of ions around
the cell is less dense than in isotonic saline
Reduced conc. of cations surrounding RBCs allow +vely
charged Abs easier to access Ag sites
Rate of sensitization increases
33
34. 5- Antigen Density
The greater the number of Ags on red cell, the greater the sensitization
Binding of +vely charged Abs to red cells lower the zeta potential
And therefore enhances agglutination
Increased Ag density also increases chance of bridging
34
35. Factors Influencing RBCs Agglutination
6- Ag Clustering and Mobility
Clustering facilitates agglutination by increasing likelihood of Ab binding at that
site
Cluster of some Ags can occur after enzyme treatment of cells
Clustering of Ags
35
36. Factors Influencing RBCs Agglutination
7- Antibody Characteristics
Ability of Ab to agglutinate cells depend on the Ig
class
IgM has a wider span than IgG, and therefore more
effective agglutination
IgG can be chemically modified to increase its span
IgMA
g
300 Ao
IgG IgG
150 Ao250-300 Ao
36
37. 8. Specificity
9. Bonding
10. Physical fit
11. Incubation time
37
40. ABH antigen
Express on RBC, platelet, epithelial cells are mainly glycospingolipids
Also present in body fluid (saliva, serum) are glycoproteins
Genes ABO,Hh, Se control the expressions of antigens.
40
41. Location
The presence or absence of the
ABH antigens on the red blood
cell membrane is controlled by
the H gene.
The presence or absence of the
ABH antigens in secretions is
indirectly controlled by the Se
gene.
41
42. H antigen
The H gene codes for an enzyme that adds sugar fucose to the terminal sugar of a
precursor substance
The precursor substance (proteins and lipids) is formed on an oligosaccharide chain
(the basic structure)
42
44. H antigen
Is the foundation upon which A and B
antigens are built.
A and B genes code for enzyme that add
an immunodominant sugars to the H
antigen
Immunodominant sugars are present at the
terminal ends of the chains and confer the ABO
antigen specificity
44
45. A antigen
The A gene codes for an enzyme
(transferase) that adds N-
acetylgalactosamine to the terminal sugar of
the H antigen
N-acetylgalactosaminyltransferase
45
46. B antigen
The B gene codes for an enzyme that
adds D-galactose to the terminal sugar
of the H antigen
D-galactosyltransferase
46
49. Certain blood types possess more H antigen than others.
Most H O>A2>B>A2B>A1>A1B
Least H
49
50. Why do Group O individuals have more H
antigen than the other groups?
Group O individuals have no A or B genes
to convert the H antigen that means more
H antigen sites
50
54. Bombay Phenotype (Oh)
Inheritance of hh
The h gene is an amorph and results in little or no production of L-fucosyltransferse
Orginally found in Bombay
Very rare (130 worldwide)
The hh causes NO H antigen to be produces
Results in RBCs with no H, A, or B antigen (patient type as O)
Bombay RBC are NOT agglutinated with anti A, anti B,or anti H(no antigens present)
Bombay serum has strong anti A, anti B and anti H, agglutinating ALL ABO blood
groups
54
55. What blood ABO blood group would you use to transfuse this patient?
Another Bombay
Group O RBC cannot be given because they still have H antigen
You have to transfuse the patient with blood that contains NO H antigen
55
56. Blood group Antigens on cell Antibodies in plasma
A A Anti-B
B B Anti-A
AB A and B Anti-AB
O None Anti A and B
56
58. Methods of Blood Grouping
Several methods can be done for ABO grouping.
Serology - direct detection of the ABO antigens. It is the main method
used in blood transfusion centre and hospital blood banks.
This form of testing involves two componenets.
1 Antibodies that are specific at detecting a particular ABO antigen on RBCs.
2 Cells that are of a known ABO group that are agglutinated by the naturally occurring antibodies in
the person’s serum
58
59. Blood grouping
Blood grouping
Forward or cell
grouping or front typing
or forward typing
Reverse or serum
grouping or confirming
grouping or back
typing
59
60. Forward grouping
Test for antigens
Patient’s cells containing unknown antigens tested with known antisera.
Reaction of patient red blood cells tested with reagent anti A and anti B antisera
Forward
grouping
Slide
method
20-40% Patient’s RBC
suspension + known antiserum
Tube
method
2-5% Patient’s RBC suspension+
known antiserum(centrifuge before
read)
60
62. Reverse grouping
Serum is combined with cells having known red cell content in a 2:1 ratio
Reverse
grouping
Slide
Method
20-40% Known red cell
suspension + patient’s serum
Tube
method
2-5% Known red cell suspension +
patient’s serum
62
67. Use of Group O cells when carrying out a serum group
Some donors have antibodies in their serum other than anti A or anti B
These antibodies are not naturally expected to be present
These are called irregular antibodies
As a result of earlier immunization , during pregnancy in the case of a woman,
previous transfusion
The presence of irregular antibodies may be demonstrated by using group O cell in
serum grouping
Viva,
MSQ
67
68. Subgroups of A (A1 and A2)
They both react strongly with reagent anti-A.
80% of group A individuals phenotype as A1
20% phenotype as A2
Reagent anti-A is a mixture of two Abs ;
anti-A which react with both A1 and A2 cells.
anti-A1 which reacts with A cells but not with A2 cells in simple testing .
68
69. Difference Between A1 and A2
A1 has more A and less H antigen on the cell.
A2 has less A and more H antigen
Cannot be detected serologically
A2 can produce anti- A1 – qualitative difference
69
70. Differentiation between the A blood subgroups
Reagent anti-A is a mixture of two Abs
Anti-A1-lectin: is another source of anti-A1.
lectins are seed extracts that agglutinate human cells with some degree of specificity.
The seeds of the plant Dolichos biflorus serve as the source of the anti-A1 lectin this
reagent agglutinate A1 or A1B cells but does not agglutinate A2 or A2B cells.
70
71. Anti-A1
1-8% of A2 and 22-35% of A2B people will have anti-A1
Causes ABO discrepancy – reverse type
Incompatible crossmatch if donor A1
NOT clinically significant unless reactive at 37C or AHG.
Clinically significant – ability to cause red cell destruction – donor blood or
hemolytic disease of the fetus and newborn.
71
72. Subgroup A Subgroup frequency Antibodies always
present
Antibodies sometimes
present
A1 80% Anti B None
A2 20% Anti B Anti A1 in 2%
A1B 80% None None
A2B 20% none Anti A1 in 25%
72
73. Anti AB
Used anti AB as a part of standard blood grouping to ensure weak A and B antigen
This mixture has a much higher affinity for weaker antigens
Not required for testing patient’s red cells
Recommended for donor blood grouping
73
74. Anti A
Consist of a mixture of two antibodies.
Anti A agglutinates A1, A2, A1B, A2B cells
Anti A1 agglutinates only A1 and A1B cells
74
75. Secretor Genes
A, B and H antigens may be present in fluids.
Controlled by Se and se, secretor genes.
Need only one copy of the Se gene.
The gene se is an amorph.
Not linked to ABO locus, inherited independently
75
77. Secretor Genes
Persons who have A, B and/or H in secretions are called “secretors”
Blood Group Substance in Secretions
A A and H
B B and H
AB A, B and H
O H
77
78. ABO & Rh D Grouping using Tile Technique
Anti A Anti B Anti AB A cell B cell Ocell Anti D
Patient ID
Patient ID
Patient ID
The blood group reagents should be dispesne according to the
labeling on the tile.
Reagents
Place one drop of anti A reagent in each of the wells in the
anti A columm.
Place one drop of anti B reagent in each of the wells in the
anti B columm. 78
79. Place one drop of anti AB reagent in each of the wells in the anti AB columm.
Place one drop of A cells (15-20% reverse cells) in each of the wells in the anti A cells column.
Place one drop of B cells (15-20% reverse cells) in each of the wells in the anti B cells
column.
Place one drop of O cells (15-20% reverse cells) in each of the wells in the anti O cells
column.
Place one drop of anti D reagent in each of the wells in the anti D column.
79
80. Samples
For each row:
Place one drop of 15-20% patient cells in each of the anti A, anti B, anti AB and anti D wells.
Place two drops of patient plasma (or serum) in each of the A cells, B cells and O cells wells.
Procedure
Mix the contents of all wells using the wooden mixing "sticks".
Gently rock the tile and then place at room temperature.
Examine for agglutination after 5 minutes.
If a weak agglutination or negative reaction is obtained, examine again after 15 minutes.
Using the Agglutination Grading chart as a guide, score the results for each well from 0-4+.
Determine the group for the control and patient samples using the Tile Group Interpretation Chart.
80
81. ABO & RhD Grouping Using Tube Technique
Principle
The ABO forward group identifies the presence or absence of ABO antigens on the red cell
surface using antibodies to those antigens. The ABO reverse group identifies the presence
or absence of naturally occurring plasma (or serum) antibodies to ABO groups must
correlate.
The Rh system is the second most important blood group system. Blood is classified as Rh
D positive or RhD negative depending on the presence or absence of the Rh D blood group
antigen.
A weakened expression of the Rh D antigen may occasionally be present on red cells.
Approximately 82% of the Caucasian populations are Rh D positive.
The ABO and Rh D blood groups of blood donors and recipients are routinely determined
to ensure that ABO and Rh D compatible blood is used for transfusion.
All blood group discrepancies must be resolved.
This procedure describes ABO and Rh D grouping tests, using test tube based techniques.
81
82. Specimen preparation
A 3-5% red cell suspension of test cells and a separated sample of patient serum (or) plasma are
required.
Materials
Patient 3-5% red cell suspension
Patient plasma or serum
ABO forward Group Typing Reagents
ABO Reverse Grouping Reagents Red Cells
Reverse cell 3% cells
Rh D Blood Grouping Reagents
Anti D
Buffered saline or Normal saline
Plastic Pipettes
82
84. Procedure
The ABO cell (forward) and plasma or serum (reverse) groups and Rh D group are performed simultaneously.
Prepare a 3-5% suspension of patient red cells as per SOP (1).
Label 7 glass test tubes (12x75 mm) with a unique patient identifer and anti A, anti B, anti AB and anti D for
cell grouping (forward group) and A cells, B cells and O cells for plasma grouping (reverse group).
Place two drops of patient plasma into the two tubes labeled A cells, B cells and O cells.
Place one drop of each grouping reagent into the appropriate tubes.
Add one drop of 3-5% test red cell suspension to each of the four tubes containing the forward grouping
reagents and add one drop of A1 and B reagent red cells (Revercells) to the 3 tubes labeled A cells, B cells
and O cells.
Gently shake all tubes to allow mixing and incubate at room temperature for 5 minutes.
Centrifuge tubes at 2000 rpm for 15 seconds or 1000 rpm for 1 minute using Immufuge or another suitable
centrifuge.
Examine for macroscopic agglutination over a light box using the roll and tip method.
Score and record results and interpretation on supplied worksheet.
84
85. Causes of False Positive Reaction
1. Rouleaux formation
-pseudo agg pile of coins due to high protein concentration
- can be differentiated from true agglutination by saline dispensing technique
2. Cold agglutinin cause auto agg, active at RT. If suspected,
- serum grouping repeated at 37C
- cell grouping repeated after washing several time in warm buffered
saline
3. Infected red cells
- poly agg – less obvious – does not occur at 37C- true group can be
done at 37C
85
86. Cause of False negative reaction
1 Use of impotent sera
Loss of potency result if sera are left at RT or stored frozen in large volume
2. No recognition of lysis
Inspected for lysis
86